Evidence map›Paper›PMID 26023237›Full record

ArticleThe Journal of biological chemistry2015

Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia.

Egle Jakubauskiene, Laurynas Vilys, Yuichi Makino, Lorenz Poellinger, Arvydas Kanopka

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Predicting human mRNA isoform levels from site-specific splicing kineticsbioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.Journal of experimental & clinical cancer research : CR · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Egle JakubauskieneDepartment of Immunology and Cell Biology, Vilnius University, Institute of Biotechnology, 02241 Vilnius, Lithuania.
Laurynas VilysDepartment of Immunology and Cell Biology, Vilnius University, Institute of Biotechnology, 02241 Vilnius, Lithuania.
Yuichi MakinoDivision of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical College, 078-8510 Asahikawa, Hokkaido, Japan.
Lorenz PoellingerDepartment of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institute, SE-17177 Stockholm, Sweden; Cancer Science Institute, National University of Singapore, 117599 Singapore.
Arvydas KanopkaDepartment of Immunology and Cell Biology, Vilnius University, Institute of Biotechnology, 02241 Vilnius, Lithuania. Electronic address: kanopka@ibt.lt.
Vilnius University · LTAsahikawa Medical College Hospital · JPKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The removal of introns from mRNA precursors (pre-mRNAs) is an essential step in eukaryotic gene expression. The splicing machinery heavily contributes to biological complexity and especially to the ability of cells to adapt to altered cellular conditions. Inhibitory PAS domain protein (IPAS), a dominant negative regulator of hypoxia-inducible gene expression, is generated from hypoxia inducible transcription factor-3α (HIF-3α) pre-mRNA by an alternative splicing mechanism. Inactivation of the IPAS transcript in mice leads to the neo-vascularization of the cornea, suggesting that IPAS is an important regulator of anti-angiogenesis in this tissue. For the first time we demonstrate that serine-arginine (SR) proteins are involved in oxygen tension-dependent changes in pre-mRNA splicing. SR proteins isolated from hypoxic cells differentially interact with RNA (compared with proteins isolated from cells cultured under normoxic conditions). They possess the differential ability to activate hypoxia-dependent splice sites, and they are more phosphorylated than those isolated from normoxic HeLa cells. We also show that expression of SR protein kinases (CLK1, SRPK1, SRPK2) in hypoxic cells is elevated at mRNA and protein levels. Increased expression of CLK1 kinase is regulated by HIFs. Reduction of CLK1 cellular expression levels reduces hypoxia-dependent full-length carbonic anhydrase IX (CAIX) mRNA and CAIX protein formation and changes hypoxia-dependent cysteine-rich angiogenic inducer 61 (Cyr61) mRNA isoform formation profiles.

Indexed as

Alternative SplicingArginineCell HypoxiaGene Expression Regulation, EnzymologicHeLa CellsHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitOxygenPhosphorylationProtein Serine-Threonine KinasesRNA PrecursorsSerineArginineHypoxia-Inducible Factor 1, alpha SubunitOxygenProtein Serine-Threonine KinasesRNA PrecursorsSerinealternative splicinghypoxiaphosphorylationRNA splicingserine/threonine protein kinasespliceosome

Identifiers

PMID26023237
PMCPMC4505053
OpenAlexW1462687379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.